Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corplex Donepezil TDS vs Aricept Bioequivalence Study
NCT03259958Phase 1Completed
- Sponsor
- Corium
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Corium. Primary endpoints: Area Under the Curve at 10 weeks and Maximum Plasma Concentration at 10 weeks. Started Oct 2017; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03259958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03259958.